PATENT CLAIM ANALYSIS

Application Number: 16079802
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "330000"]

Abstract:
Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.

Claim (Index 24):
A compound for use in a method of treating a solid tumor in a subject, wherein the compound is a mutant isocitrate dehydrogenase 1 (IDH1) inhibitor (S)\u2014N\u2014((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide having the following formula: or a pharmaceutically acceptable salt, solvate, tautomer, stereoisomer, isotopologue, prodrug, metabolite, or a polymorph thereof (COMPOUND 2), wherein the solid tumor is characterized by the presence of a mutant allele of IDH1 and the absence of a FLT3 mutation.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15368405', '15767822', '15368439', '15768462', '15125880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8376537432527285
- 35 USC 102 Novelty (BERT): 0.5664184299969428
- Combined Prediction Score: 0.8105302119271499
- Mean Citation Score: 462.025804
- Max Citation Score: 504.7606
- Similarity Product: 436.600173028779

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test